[Federal Register Volume 74, Number 103 (Monday, June 1, 2009)]
[Notices]
[Pages 26246-26248]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12630]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-0920-09BS]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to <a href="/cdn-cgi/l/email-protection#f39c9e91b3909790dd949c85"><span class="__cf_email__" data-cfemail="b7d8dad5f7d4d3d499d0d8c1">[email protected]</span></a>.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the

[[Page 26247]]

agency's estimate of the burden of the proposed collection of 
information; (c) ways to enhance the quality, utility, and clarity of 
the information to be collected; and (d) ways to minimize the burden of 
the collection of information on respondents, including through the use 
of automated collection techniques or other forms of information 
technology. Written comments should be received within 60 days of this 
notice.

Proposed Project

    Formative Evaluation and Message Testing to Inform the Development 
of Health Promotion Materials for the National Hemophilia Foundation's 
Hemophilia and AIDS/HIV Network for the Dissemination of Information 
(HANDI)--NEW--National Center on Birth Defects and Developmental 
Disabilities (NCBDDD), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    The Division of Blood Disorders, located within the National Center 
on Birth Defects and Developmental Disabilities, implements health 
promotion and wellness programs designed to prevent secondary 
conditions in people with bleeding and clotting disorders. These 
programs are carried out in partnership with community-based 
organizations on the national and local level. The division's largest 
and longest standing cooperative agreement is held by the National 
Hemophilia Foundation (NHF). NHF, founded in 1948, has a long history 
of service through education, advocacy and research for people and 
families with hemophilia and other bleeding disorders.
    The Hemophilia and AIDS/HIV Network for the Dissemination of 
Information (HANDI) is NHF's resource center which provides 
information, materials, and support to people with bleeding and 
clotting disorders. Over the past 17 years, HANDI's resource collection 
has grown to meet the changing needs of the community. HANDI processes 
thousands of requests for information from a wide variety of 
individuals and organizations including NHF chapters, medical 
professionals, consumers and their families, and teachers and students 
conducting research. The types of information requested reflect a 
diversity of needs--topics include home care, orthopedics, physical 
therapy, rare factor deficiencies, psychosocial issues, blood safety, 
women's health, and financial and insurance reimbursement issues. 
HANDI's current resource library collection contains nearly 13,000 
items. However, the process by which materials have been selected for 
development has not been informed by a systematic needs assessment or 
other exploratory research. Therefore it is not known if the materials 
and messages that have been developed are meeting the information needs 
of the audiences they were intended to serve.
    While there seems to be many HANDI materials available that focus 
on parents and family members of newly diagnosed children, considerably 
less attention has been given to developing materials for young 
children and adolescents, particularly materials that address 
transition issues. There are many types of transitions for the person 
with a bleeding disorder. These include acceptance of the bleeding 
disorder, self care, progressing through school, vocational/career 
planning, moving to an adult center, starting a family, middle age, and 
retirement. Transition occurs throughout life for all people, but for 
those with chronic illness, it takes on additional significance due to 
the nature of their condition.
    The CDC's Division of Blood Disorders in conjunction with the 
National Hemophilia Foundation will conduct focus groups to gather 
information that will be used to design educational materials and 
health promotion programs for young children (aged 5-12 years) and 
adolescents (aged 16-19 years) that address transition issues. Focus 
groups will be used to explore the type of information, resources, and 
support young children and adolescents need related to transition 
issues. The groups will also be used to explore how young children and 
adolescents prefer to receive health messages and health information 
(e.g., brochures, videos, podcasts, U-tube, etc.). These findings will 
inform the development of key messages tailored to the target audiences 
that will then be tested during another set of focus groups to see how 
well the messages resonate with the intended end users.
    The Contractor selected will work with CDC and NHF, through its 
chapter network, to identify and recruit focus group participants. 
Formative research participants will include parents of young children 
(aged 5-12 years), parents of teenagers or young adults who can reflect 
back upon their experience and share what information, resources, and 
support they wished had been available when their child was young, and 
adolescents (aged 16-19 years). Message testing participants will 
include parents of young children (aged 5-12 years) and adolescents 
(aged 16-19 years). Participants will be recruited to participate in 
one of sixteen in-person focus groups that will be conducted in the 
following cities:
    <bullet> Detroit, Atlanta, Philadelphia, San Francisco (for the 
formative research task), and
    <bullet> Milwaukee, Houston, Boston, and San Diego (for the message 
testing task)
    There are no costs to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
                   Respondents                       Number of     responses per   per response    Total  burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Parents (formative groups)......................              36               1               2              72
Adolescents (formative groups)..................              36               1               2              72
Parents (message testing groups)................              36               1               2              72
Adolescents (message testing....................              36               1               2              72
groups).........................................
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............             288
----------------------------------------------------------------------------------------------------------------



[[Page 26248]]

    Dated: May 26, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E9-12630 Filed 5-29-09; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>